Endo

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Endo may sell assets as reliance on price hikes wanes

Pharmalot By Ed Silverman

Cash is not king: FTC sues drug maker over pay-to-delay deal

Pharmalot By Ed Silverman

Drug maker fined by New York over improper opioid marketing